Search

Your search keyword '"Rana, R"' showing total 296 results

Search Constraints

Start Over You searched for: Author "Rana, R" Remove constraint Author: "Rana, R" Topic medicine Remove constraint Topic: medicine
296 results on '"Rana, R"'

Search Results

1. 46th Medical Maghrebian Congress. November 9-10, 2018. Tunis.

2. Liraglutide Attenuates Diabetic Cardiomyopathy via the ILK/PI3K/AKT/PTEN Signaling Pathway in Rats with Streptozotocin-Induced Type 2 Diabetes Mellitus

3. Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study

4. Trends of kidney cancer burden from 1990 to 2019 in European Union 15 + countries and World Health Organization regions

5. Feeding practices and growth patterns of moderately low birthweight infants in resource-limited settings: results from a multisite, longitudinal observational study

6. Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study

7. A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer

8. Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy.

9. Sequencing of PD-1/L1 Inhibitors and Carboplatin Based Chemotherapy for Cisplatin Ineligible Metastatic Urothelial Carcinoma

10. Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials

11. Disparities in germline testing among racial minorities with prostate cancer

12. Asymptomatic detection of SARS‐CoV‐2 among cancer patients receiving infusional anti‐cancer therapy

13. Synthesis and Diagnoses of New Metal Ions Complexes derived from Trimethoprim Schiff Bases

14. Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate Cancer

15. Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma

16. Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer

17. Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans

18. Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer

19. Next Steps: Sequencing Therapies in Metastatic Kidney Cancer in the Contemporary Era

20. Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance

21. Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer

22. Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes

23. NCCN Guidelines Insights: Prostate Cancer, Version 1.2021

24. The potential of intranasal delivery of nanocrystals in powder form on the improvement of zaleplon performance: in-vitro, in-vivo assessment

25. Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma: A Response-Based Phase II Study (OMNIVORE)

26. Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTC

27. Olfactory Ensheathing Cells Express α7 Integrin to Mediate Their Migration on Laminin.

28. Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies

29. Accelerating precision medicine in metastatic prostate cancer

30. Immunotherapy for Localized Prostate Cancer

31. Outcomes of Black men with prostate cancer treated with radiation therapy in the Veterans Health Administration

32. The Impact of Age and Gender on Outcomes of Patients With Advanced Renal Cell Carcinoma Treated With Targeted Therapy

33. Plasma cell-free DNA variant analysis compared with methylated DNA analysis in renal cell carcinoma

34. Testosterone therapy does not increase the risks of prostate cancer recurrence or death after definitive treatment for localized disease

35. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

36. Up-regulation of Antioxidant Status in Chronic Renal Failure Rats Treated with Mesenchymal Stem Cells and Hematopoietic Stem Cells

37. Recent Advances in the Management of High-Risk Localized Prostate Cancer: Local Therapy, Systemic Therapy, and Biomarkers to Guide Treatment Decisions

38. Microbiome analyses of blood and tissues suggest cancer diagnostic approach

39. Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group

40. It Takes a Village: The First 100 Patients Seen in a Multidisciplinary Pelvic Floor Clinic

41. Systemic Treatment of Bone Disease in Metastatic Urinary Malignancies

42. Neoadjuvant Approaches Prior To Radical Prostatectomy

43. New-Onset Refractory Status Epilepticus in Children

44. Utility of FDG-PET/CT in Patients with Advanced Renal Cell Carcinoma with Osseous Metastases: Comparison with CT and 99mTc-MDP Bone Scan in a Prospective Clinical Trial

45. Response of Primary Renal Cell Carcinoma to Systemic Therapy

46. Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19

47. Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study

48. The Promise of Adjuvant Immunotherapy in Renal-Cell Carcinoma

49. Treatment Discontinuation in Patients With Muscle-Invasive Bladder Cancer Undergoing Chemoradiation

50. The Microbiome and Prostate Cancer

Catalog

Books, media, physical & digital resources